SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-027972
Filing Date
2024-03-29
Accepted
2024-03-29 16:05:34
Documents
13
Period of Report
2024-03-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea0202916-8k_chinapharma.htm   iXBRL 8-K 23441
  Complete submission text file 0001213900-24-027972.txt   197625

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cphi-20240327.xsd EX-101.SCH 3024
3 XBRL LABEL FILE cphi-20240327_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cphi-20240327_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0202916-8k_chinapharma_htm.xml XML 3713
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 24804143
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)